Skip to content

Randomised trial, 2001

Does venlafaxine help treat PMDD?

Yes, venlafaxine was significantly more effective than placebo. 43% of women on venlafaxine had full symptom remission compared to 25% on placebo, with most benefit appearing in the first treatment cycle.

Strong study design 164 women with PMDD

What they did

164 women with PMDD were randomly assigned to take venlafaxine (flexible dose 50-200 mg/day) or placebo for four menstrual cycles. Researchers measured symptoms daily using rating scales.

What they found

Venlafaxine reduced symptoms significantly more than placebo across mood, function, pain, and physical symptoms. 43% of venlafaxine users versus 25% of placebo users had symptom remission. Approximately 80% of symptom reduction happened in the first treatment cycle. Mean dose was 50 mg/day in cycle 1 and increased to 130 mg/day in cycle 4. Side effects like nausea, insomnia, and dizziness were mild and temporary.

What it means for you

Venlafaxine works well for PMDD and works quickly, with mild side effects. The main limitation is that we don't yet know if taking it only during the luteal phase works as well as daily dosing.

43% vs 25%

remission rates

80% reduction

symptom improvement cycle 1

130 mg/day

mean dose cycle 4

About the study

Original title
Venlafaxine in the treatment of premenstrual dysphoric disorder
Authors
Freeman EW, Rickels K, Yonkers KA et al.
Journal
Obstetrics and gynecology
Year
2001
Study design
Randomised trial
Participants
164
What was tested
Venlafaxine 50-200 mg/day (flexible dosing) versus placebo for 4 menstrual cycles

Topics